Healthcare -
Biotechnology - NASDAQ - US
$ 53.55
-0.557 %
$ 6.6 B
Market Cap
14.24
P/E
HALO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities HALO - Halozyme Therapeutics, Inc.
-219 M
LAST VALUE
-26.65%
2 YEAR CAGR
-19.42%
5 YEAR CAGR
-11.28%
10 YEAR CAGR